Document Library

OrganizationSummarySubject AreaTypeLinkhf:doc_categorieshf:doc_tags
Best and Promising Practices with Erik Steele, DO

Erik Steele, D.O. is a family physician practicing family medicine primary at the nonprofit primary …

, , educational-resources practicesvideo webinar
Integrating Peer Support Roles into Interdisciplinary Teams for Substance Use Services

February 15, 2024 | Randy Morrison, MPH, …

, , , adolescence educational-resources peer-supportvideo webinar
Alcohol Withdrawal for Nursing

Alcohol Withdrawal for Nursing | February 23, 2024 | Amelia Hersey, …

, , alcohol educational-resourcesvideo webinar
The Intersection of SUD, Trauma, and Homelessness

, echovideo webinar
Engagement/motivational Interviewing for Decreasing EtOH Use

, , alcohol echovideo webinar
An Update on Pharmacotherapy Development for Cannabis Use Disorder

, , cannabis echovideo webinar
Proposed Position on Supervised Withdrawal Management (December 2023)

, practices provider-informationdocument
Risk Stratification for Alcohol Withdrawal Management

Join the ME SUD Learning Community in the series Project ECHO: Ambulatory Alcohol Withdrawal Management …

, , alcohol echovideo webinar
Engagement/Motivational Interviewing for Decreasing EtOH Use

Join ME SUD Learning Community’s Project ECHO; Ambulatory Alcohols Withdrawal Management and Treatment entitled “Engagement/ …

, , echo educational-resourcesvideo webinar
A Losing Hand: Gambling Among Patients

A Losing Hand: Gambling Among Patients with OUD | February 2, 2024 | Rick Berman, …

, educational-resourcesvideo webinar
Reduced Use of Stimulants Study

Andrea Truncali, MD MPH , Feb 2024

, document prescribing
National Model Standards for Peer Support Certification (Spanish Version)

This Spanish model standards guidance document, SAMHSA’s National Model Standards for Peer Support Certification, is …

, peer-supportdocument link
National Model Standards for Peer Support Certification (English)

This model standards guidance document, SAMHSA’s National Model Standards for Peer Support Certification, is prepared …

, peer-supportdocument link
Consumer Guide: How Can a Peer Specialist Support My Recovery From Problematic Substance Use? For People Seeking Recovery

SAMHSA This new consumer guide offers people with past or current problematic substance use a …

, peer-supportdocument link
Low Barrier Models of Care for Substance Use Disorders

Low Barrier Models of Care for Substance Use Disorders | January 22, 2024 | Robert …

, educational-resourcesvideo webinar
Adolescents & Young Adults ECHO | An Update on Pharmacotherapy Development for Cannabis Use Disorder

, , , adolescence cannabis echo educational-resources
Treatment Considerations in Patients who have Bipolar Disorder and are Pregnant or Postpartum

Speaker: Stephanie Nichols, PharmD, BCPP, BCPS, MPH This session will focus on reviewing bipolar disorder …

, educational-resourcesvideo webinar
Adding Fentanyl Testing to Hospital Toxicology Assays

Speakers: Alane O’Connor, DNP, Robert Carlson, MD, and Scoott Lowell, MHA, MLS (ASCP) This webinar …

, , educational-resources fentanylvideo webinar
Non Suicidal Self-Injurious Behavior in Adolescents with OUD/SUD

, , adolescence echovideo webinar
Alcohol Use Disorder and Withdrawal Management

Alcohol Use Disorder and Withdrawal Management | December 15, 2023 | Brain Fuehrlein, MD, PhD …

, , alcohol educational-resourcesvideo webinar
Advisory: Low Barrier Models of Care for Substance Use Disorders

The Advisory outlines the principles and components of low barrier care, and how low barrier …

Best and Promising Practices | Adding Fentanyl Testing to Hospital Toxicology Assays

, , , educational-resources fentanyl provider-informationvideo webinar
Cytochrome P Four Who? Demystifying Pharmacokinetic Drug Interactions

Stephanie Nichols, PharmD, MPH, BCPP, BCPP, BCPS, FCCP | November 28, 2023 Do you struggle …

, , educational-resources provider-informationvideo webinar
Cannabis Use and Psychosis in Adolescents

November 29, 2023 | Amy M. Mayhew, MD, MPH This presentation will investigate cannabis use …

, , , , adolescence cannabis educational-resources provider-informationvideo webinar
Medications for Alcohol Use Disorder

December 5, 2023 Presented by: Stephanie Nichols, PharmD, BCPP, BCPS, …

, , alcohol educational-resourcesvideo webinar
Effectiveness of Prazosin in AUD Study

Alcohol use disorder (AUD) is a disease that affects one in seven people. 1  And …

document
Clinical Provider Quick Tips: Addressing Substance Use in Primary Care Settings

, fentanyl stimulantlink
Xylazine 101 | Cara Zimmerman, MD, MBA | November 7, 2023

, , educational-resources xylazinevideo webinar
Alcohol Use During the Perinatal Period | Alane O’Connor, DNP | October 23, 2023

, educational-resourcesvideo webinar
Understanding the Complex Intersection of Co-Occurring Depression and Substance Use Disorders | Jonathan Fellers, MD, PA, LLC | September 28, 2023

, educational-resourcesvideo webinar
OUD/SUD and Anxiety | Kevin Simon, MD, MPH | September 14, 2023

, educational-resourcesvideo webinar
Extended-Release Buprenorphine During Pregnancy and Postpartum | Alane O’Connor, DNP | August 23, 2023

, educational-resourcesvideo webinar
Substance Use Screening, Brief Intervention, and Referral to Treatment | Kennebec Region Health Alliance Primary Care Forum

, educational-resourcesvideo webinar
Bipolar Disorder and SUDs | Stephanie Nichols, PharmD, BCPS, BCPP | June 20, 2023

, educational-resourcesvideo webinar
Harm Reduction 2.0 | Unsafe Supply: Clinical Practice Implications and Future Directions | Anna McConnell, FNP-BC, and Kinna Thakarar, DO | June 7, 2023

, educational-resourcesvideo webinar
Nicotine Vaping: What Should Providers Tell Their Patients? What about that Cough? | Jonathan Fellers, MD | June 1, 2023

, educational-resourcesvideo webinar
Nursing Management of Withdrawal of Alcohol and Opioids | Amelia Hersey, PA-C | May 31, 2023

, educational-resourcesvideo webinar
The Invitation to Change Approach | Nicole Kosanke, PhD | May 10, 2023

, educational-resourcesvideo webinar
Anxiety and Substance Use Disorders | Petros Levounis, MD, MA | April 13, 2023

, educational-resourcesvideo webinar
Enhancing Access to Medications for Opioid Use Disorder for Patients in Hospital Settings | Alane O’Connor, DNP and Rachel Solotaroff, MD | April 4, 2023

, educational-resourcesvideo webinar
Addiction in LGBTQ+ Communities and Crystal Methamphetamine | Petros Levounis, MD, MA | March 30, 2023

, educational-resourcesvideo webinar
Justice Involved Individuals with OUD | Alane O’Connor, DNP | March 21, 2023

, educational-resourcesvideo webinar
Emotionally Reactive or Highly Avoidant: the art of medication management for co-occurring substance use disorder and borderline personality disorder in non-specialty care settings | Hilary S. Connery, MD, PhD | March 16, 2023

, educational-resourcesvideo webinar
Non-Prescribed Gabapentin: Why is it happening and why is it important?

, educational-resourcesvideo webinar
Post-Acute and Long-Term Care Facilities: Prescribing and Managing OUD and AUD | Amelia Hersey, PA-C | March 7, 2023

, educational-resourcesvideo webinar
How to Respond Proactively to Patient Behavior in MOUD and Chronic Pain Environments

, educational-resourcesvideo webinar
The Role of Low-Threshold Treatment for Patients with OUD in Primary Care

, buprenorphine educational-resources
16 vs 24 mg: Beyond the Headlines

Greetings, colleagues! In the era of fentanyl, we wonder, is more buprenorphine better? Or does …

, , data-analytics educational-resourcesdocument prescribing
Organizational Management

The Maine Organizational Management module allows chief medical officers, medical directors, and other medical supervisors …

pmp
How to find the Maine PMP Prescriber Report

pmp
Identifying Higher-Risk Prescribers: Prescribing Thresholds by Medical Specialty

The Maine Prescription Monitoring Program (PMP) utilizes specialty-specific clinical thresholds as a component of the …

pmp
Proposed Position on Fentanyl Toxicology Testing

, , fentanyl position-statementdocument link
Managing Legacy Patients on Controlled Substances: Compassionate, Evidence-Based Responses

Managing Legacy Patients on Controlled Substances: Compassionate, Evidence-Based Responses | June 27, 2023 | Noah …

, pmpvideo webinar
Medication Deprescribing and Chronic Pain Care

Webinar Medication Deprescribing and Chronic Pain Care | July 11, 2023 | Eva Quirion, NP, …

, pmpvideo webinar
Colorado’s Experience with Cannabis: A Public Health Perspective

Webinar Colorado’s Experience with Cannabis: A Public Health Perspective| July 25, 2023 | Richard Holdman, …

, pmpvideo webinar
PMP Tools to Improve Controlled Substance Prescribing

Webinar PMP Tools to Improve Controlled Substance Prescribing | June 6, 2023 | Elisabeth Fowlie …

, pmpvideo webinar
Safe and Effective Opioid Practices in the Hospital: Pharmacy Perspective

Webinar Safe and Effective Opioid Practices in the Hospital: Pharmacy Perspective | August 8, 2023 …

, pmpvideo webinar
Strategies for Solving the Opioid Epidemic and Treatment of Acute Pain

Webinar Strategies for Solving the Opioid Epidemic and Treatment of Acute Pain | August 15, …

, pmpvideo webinar
Legal Issues and Controlled Substance Prescribing: How to Make It Work for ME

Webinar Legal Issues and Controlled Substance Prescribing: How to Make It Work for ME | …

, pmpvideo webinar
Xylazine Basics: Overdose Prevention, Harm Reduction, and Wound Care

educational-resourcesdocument
Project Echo

Adolescent and Young Adults Project …

, echo educational-resources
Introduction to the Fourth Edition of the ASAM Criteria

The revised 2023 Fourth Edition of The ASAM Criteria is soon to be released. This …

educational-resources
Alcohol Use and Your Health via CDC

, healthwise sbirt
Facts About Aging and Alcohol via National Institute on Aging

, healthwise sbirt
Basic Information on Alcohol

, healthwise sbirt
Substance Use Disorders in Older Adults

, healthwise sbirt
Breastfeeding: Tobacco, Alcohol, and Drugs

, healthwise sbirt
Alcohol Effects on a Fetus

, healthwise sbirt
Alcohol or Drug Use During Pregnancy

, healthwise sbirt
Helping Your Child Avoid Tobacco, Drugs, and Alcohol

, healthwise sbirt
Substance Use Disorder: Dealing With Teen Substance Use

, healthwise sbirt
Teen Substance Use: Making a Contract With Your Teen

, healthwise sbirt
Teen Alcohol and Drug Use

, healthwise sbirt
Alcohol Use Disorder

, healthwise sbirt
Drinking and Your Health

, healthwise sbirt
Interactive Tool: Do You Have a Drinking Problem?

, healthwise sbirt
Substance Use Disorder: Care Instructions

, healthwise sbirt
Substance Use and Pregnancy: Care Instructions

, healthwise sbirt
Learning About Substance Use Disorder and Your Teen

, healthwise sbirt
Learning About Substance Use Screening in Children and Teens

, healthwise sbirt
Learning About Methamphetamines

, healthwise sbirt
Learning About Substance Use Disorder

, healthwise sbirt
Marijuana Use in Teens: Care Instructions

, healthwise sbirt
Marijuana Use: Care Instructions

, healthwise sbirt
Blood Alcohol Test for Your Teen: About This Test

, healthwise sbirt
Learning About Alcohol Use in Teens

, healthwise sbirt
Alcohol Intoxication

, healthwise sbirt
Learning About Fetal Alcohol Syndrome (FAS) in Newborns

, healthwise sbirt
Learning About Alcohol Use Disorder

, healthwise sbirt
Many helpful links for Providers and Staff

, healthwise sbirt
SBIRT Toolkit (Excel)

, implementation sbirt
SBIRT Laminator

, implementation sbirt
SBIRT: A Step-By-Step Guide

, implementation sbirt
Planning and Implementing Screening and Brief Intervention for Risky Alcohol Use

, implementation sbirt
Implementing SBIRT (Screening, Brief Intervention and Referral to Treatment) in primary care: lessons learned from a multi-practice evaluation portfolio

, implementation sbirt
How to Conduct a Fruitful Conversation about Substance Use

, implementation sbirt
Handout on Risk and Clinical Actions

, implementation sbirt
Brief-Intervention-and-Referral-to-Treatment-SBIRT/SMA13-4741

, implementation sbirt
Hilton Adolescent SBIRT Curricula

, implementation sbirt
Workflow for SBIRT at RFGH

Learn more about …

, educational-resources sbirt
PC Plus Peer Sharing – Workflow Readiness Checklist

, educational-resources sbirt
Xylazine & Opioid Use: An Update

Participants will review current opioid overdoses driven by fentanyl and xylazine, adverse and long-term effects …

educational-resources
Xylazine in the Drug Supply

Xylazine causes really bad skin ulcers when injected, even beyond the site of injection, like …

educational-resources
Xylazine Wound Care Handout

A cutting agent making its way into the drug supply. Contamination with xylazine increases risk …

educational-resources
PMP Referral Process for Prescribers

The Maine Office of Behavioral Health’s Prescription Monitoring Program periodically review prescribing patterns of all …

pmpdocument
What is Xylazine?

What is Xylazine?
− A non-opioid agent that the FDA originally approved in 1972 as a sedative and analgesic for use in veterinary medicine (not FDA approved for use in humans)
− Acts as a central alpha-2-adrenergic receptor agonist in the brainstem (like clonidine)
o Rapid decrease in the release of norepinephrine and dopamine in the central nervous system (CNS)
o May also bind to other CNS receptors

, , educational-resources patient-provider-information provider-information
Proposed Position on Enhancing Access to Extended-Release Buprenorphine for Patients with Opioid Use Disorder (May 2022)

Proposed Position on Promoting Medications for Opioid Use Disorder (MOUD) in Hospital Settings (February 2023)

Proposed Position on Ensuring Access to Medications for Opioid Use Disorder (MOUD) in Post-Acute Care Facilities (November 2021)

Frequently Asked Questions: MaineCare / Change Health Care Prior Authorization Processes for Buprenorphine for Treatment of Opioid Use Disorder

MaineCare Prior Authorization Form #20100 for Buprenorphine/Naloxone and Monoproduct Buprenorphine

Important Updates to MaineCare Coverage and Prior Authorization Criteria for Buprenorphine for Treatment of Opioid Use Disorders

Treatment of Co-Occurring Stimulant Use Disorder in Patients with Opioid Use Disorder (OUD) (October 2020)

Proposed Position on the Perioperative Management of Patients Prescribed Buprenorphine for Opioid Use Disorder (OUD) (August 2020)

Proposed Position on the Use of Buprenorphine-Naloxone in Pregnancy (March 2020)

, educational-resources provider-information
State of Maine Opioid Response

State of Maine Opioid Response …

educational-resources
PMP Check Workflow

, pmppmp workflow
Substance Use and Co-occurring Infectious Diseases

December 21, 2022 | Kinna Thakarar, DO, MPH Learning objectives: Recognize the interplay between Infectious …

educational-resourcesvideo
Harm Reduction Kinna Thakarar

November 30, 2022 | Kinna Thakarar

Learning objectives:

Review harm reduction approaches
Understand the roles of syringe service programs
Understand how to incorporate harm reduction principles in your current work with people who use drugs

, educational-resourcesvideo webinar
Cannabis and Cannabis Use Disorder: Updates for Clinicians on a Complex Topic

December 6, 2022 | Kevin M. Gray, M.D., Professor of Psychiatry and Behavioral Sciences, Medical …

, educational-resourcesvideo webinar
Urine Toxicology Testing in Substance Use Disorder Treatment

December 12, 2022 | Dr. Alane O’Connor, DNP Urine toxicology testing can be a useful …

, educational-resourcesvideo webinar
Diagnosis and treatment of ADHD in adults with Substance Use Disorder: Applying Evidence to a Common Clinical Quandry

Diagnosis and Treatment of ADHD in Adults with Substance Use Disorder: Applying Evidence to a Common Clinical Quandary | November 10, 2022 | Andrea Truncali, Lauren Moran, and Margaret Chaplin

Diagnosis and treatment of adult ADHD is on the rise. Patients with substance use disorder are thought to be disproportionately affected by ADHD but how safe is, and what impact does the pharmacologic treatment have?

, , educational-resources provider-informationvideo webinar
Pain Management and Opioids CME & Disclosures

NEJM Knowledge+ Pain Management and Opioids consist of 62 in-depth, case-based scenarios developed by practicing …

, educational-resources provider-information
Methadone Transitioning to Buprenorphine

November 3, 2022 | Jonathan C Fellers, MD

Learning objectives:

Understand the pharmacologic differences between buprenorphine and methadone
Describe 2 strategies for switching between buprenorphine and methadone
Discuss informed consent and considerations for patients

, educational-resourcesvideo webinar
What does this mean for ME: Legal and Prescribing Issues

November 14, 2022 | Ben Townsend and Elisabeth Fowlie Mock
This program will review current legal requirements for Maine opioid prescribers and the possible effects of current law enforcement activity

, educational-resourcesvideo webinar
Universal Screening, Brief Intervention, Referral to Treatment (SBIRT) within Primary Care

November 9, 2022 | Eric Haram, LADC

Universal screening and brief intervention and referral for substance misuse within primary care settings is a foundation activity soon to be required under PCPlus. This program will review the nuts and bolts to help providers implement this evidence-based practice. Screening tools to be highlighted include CRAFFT, DAST, AUDIT, 4Ps.

, educational-resourcesvideo webinar
Resources for Prescribers Regarding Controlled Substance Prescribing and Responding to Disruptions in Care-Maine November 2022

Technical Assistance,
Guidance Documents,
Handouts,
Recorded Webinars/ Online trainings,
Patient Handouts

Educational Tips for Providers Inheriting Patients on Chronic Opioid medications for pain

General Educational Guidelines from the Maine Substance Use Disorder Learning Community Faculty
Eva Quirion, FNP, Ph.D., with contributions from Andrea Truncali, MD, MPH, Jonathan Fellers, MD, Stephanie Nichols, PharmD, BCPS, BCPP
https://mesudlearningcommunity.org/

educational-resources
Methadone for Chronic Pain Tapering

General Educational Guidelines from the Maine Substance Use Disorder Learning Community Faculty
Jonathan Fellers, MD, with contributions from Eva Quirion, FNP, Stephanie Nichols, PharmD, BCPS, BCPP, https://mesudlearningcommunity.org/

educational-resources
Deprescribing Chronic Benzodiazepines

General Educational Guidelines from the Maine Substance Use Disorder Learning Community Faculty
Jonathan Fellers, MD, with Stephanie Nichols, PharmD, BCPS, BCPP
https://mesudlearningcommunity.org/

educational-resources
101 Best and Promising Practices | York Recovery Center: Creating Rapid Access and Medications First

Promising Practice Series: 30-minute Talks with Dr. Lisa Letourneau and Maine leaders
Christine Munroe, DO
Director at the Recovery Center
Eric Haram, LADC, Haram Consulting LLC.

102 Best and Promising Practices | Expanding Treatment Programs to Higher Acuity Patients

Recorded on April 27, 2022 for the Maine SUD Learning Community
Promising Practice Series: 30-minute Talks with Dr. Lisa Letourneau and Maine leaders Andrea Truncali, MD, MPH, and Christine Wyman, LCSW, LADC, CCS

103 Best and Promising Practice | Integration of Peers into Medical Practices Treating SUD with Randy Morrison

Talks with Dr. Lisa Letourneau and Randy Morrison, Director of Peer Services at Maine Health

104 Best and Promising Practice | Gilman Clinic: Tips on Treating Hepatitis C in Individuals with SUD/OUD

Recorded on May 20, 2022 for the Maine SUD Learning Community. Promising Practice Series: 30-minute Talks with Dr. Lisa Letourneau and Maine leader Kinna Thakarar, DO, MPH.

105 Best and Promising Practice | PenBay Family Medicine Rockport: Making Effective Workflows in Primary Care

Promising Practice Series: 30-minute Talks with Dr. Lisa Letourneau and Maine leader Kendra Emery, DO, Medical Director of Integrated Medication-Assisted Treatment (IMAT) and Department Chair of Family Medicine.

106 Best and Promising Practice | St Joseph’s Healthcare XR Buprenorphine Practice: Successes and Challenges

Promising Practice Series: 30-minute Talks with Dr. Lisa Letourneau and Maine leader Eva Quirion, NP

107 Best and Promising Practice | Groups Recover Together

Promising Practice Series: 30-minute Talks with Dr. Lisa Letourneau and Maine leaders | Jacob Crothers, MD and Rhonda P. Selvin, FNP

Changing Risks of Benzodiazepines Across the Lifespan

June 23, 2022 | Jonathan Fellers, MD

Learning objectives:

Explore the indications and treatment frame for the use of benzodiazepines
Understand the risks of benzodiazepines, including higher risk situations such as comorbidity
Discuss strategies for deprescribing benzodiazepines

When a Patient with Chronic Pain Loses their Provider: Compassionate, Evidence-based Responses

November 2, 2022 | Elisabeth Mock, MD, MPH and Noah Nesin, MD
What are the best actions to take when patients with chronic pain in a community suddenly lose their provider? Patients on high dose opioids often have difficulty finding new providers. What resources are available to support prescribers in such a transition?

Cannabis Research: Complexities and Priorities

November 1, 2022 | Susan R.B. Weiss
The presenter will clarify cannabis, cannabinoids, and the endocannabinoid system. After examining the evolving landscape and the effects of long-term cannabis use, the public health impacts of cannabis will be discussed.

Objectives

Understand cannabis, cannabinoids, and the endocannabinoid system
Discuss the evolving landscape of cannabis use
Examine long term health effects of cannabis
Discuss the public health impact of cannabis

Illicit Drug Supply 2022: More potent methamphetamine forms and mixtures of fentanyl, and the “Xines” and “Xenes”

October 25, 2022 | Richard Rawson, PhD

An undeniable fact of the 2022 illegal drug supply is that it is changing rapidly and it is much more lethal. Methamphetamine with far greater purity and potency and fentanyl mixed into “heroin” cocaine and meth, fentanyl pressed into a variety of pill forms, and potent drugs including xylazine (a veterinary tranquilizer) and isotonitazene a potent opioid are now part of the drug landscape.

Learning objectives:

Understand the new street drug supply to provide effective overdose care and treatment.

Contingency Management: Essential Treatment Approach for Individuals with Stimulant Use Disorder

October 18, 2022 | Richard Rawson, PhD

Contingency Management (CM) is a powerful behavioral strategy that has repeatedly been demonstrated to reduce stimulant use by individuals with Stimulant Use Disorder. Use of CM outside of the VA has been rare due to regulatory and funding obstacles. However, CM is cited in the 2022 National Drug Plan as a priority treatment to address the treatment needs of individuals with cocaine and methamphetamine use disorder. Delivery of an effective, evidence-based CM protocol that is in compliance with federal guidelines requires careful development of a training and implementation plan. The presenter will present the steps and key components of the CM protocol and implementation plan being used in California in the first large scale implementation of CM outside the VA.

Ambulatory Alcohol Withdrawal Management

October 11, 2022 | Nick Piotrowski, MD, FASAM, Medical Director, Addiction Psychiatry, MBH

Many patients can receive treatment for alcohol withdrawal safely in the community with the support of a primary care provider. This program will provide an overview of key elements and safety considerations of ambulatory alcohol withdrawal management programs.

Objectives:

Describe the role of ambulatory alcohol withdrawal management in the ASAM continuum of care.
Name 4 essential components of an ambulatory alcohol withdrawal management program.
Outline advantages and disadvantages of using benzodiazepines for ambulatory alcohol withdrawal management.

Medications and Treatment for Alcohol Use Disorder

October 4, 2022 | Sephanie Nichols, PharmD MPH and Eric Haram, LADC

Objectives:

Understand prescribing and treatment for Alcohol Use Disorder
Describe ways to engage with patients when discussing unexpected information

Complex Persistent Opioid Dependence

October 4, 2022 | Mark Sullivan

Learning Objectives:

Learn the prevalence of Opioid Use Disorder (OUD) in patients treated with long-term opioid therapy (LTOT) for chronic pain
Understand the difference between OUD and Complex Persistent Opioid Dependence among patients on LTOT
Learn how to manage Complex Persistent Opioid Dependence
Differentiating Dependence from Opioid Use Disorder Maine

Update on 2022 PMP Enhancements

September 29, 2022 | Elisabeth Fowlie Mock, MD

Multiple enhancements to the Maine PMP in 2022 will further its mission “to promote the public health and welfare and to detect and prevent substance misuse.” Tune in to learn about PMP tools to enhance patient safety and how to ensure documentation of your compliance with the 2016 Chapter 488 law. Dr. Mock has been serving as the Clinical and Policy Advisor to the PMP since January 2022.

Objectives:

Use the PMP as a tool for patient safety
Evaluate PMP check workflows
Understand the ‘Overdose Risk Score’
Review new PMP functionalities

pmppmp
Medications for Youth with an OUD and other Treatment/Recovery Considerations

September 29, 2022 | Elisabeth Fowlie Mock, MD

Multiple enhancements to the Maine PMP in 2022 will further its mission “to promote the public health and welfare and to detect and prevent substance misuse.” Tune in to learn about PMP tools to enhance patient safety and how to ensure documentation of your compliance with the 2016 Chapter 488 law. Dr. Mock has been serving as the Clinical and Policy Advisor to the PMP since January 2022.

Objectives:

Use the PMP as a tool for patient safety
Evaluate PMP check workflows
Understand the ‘Overdose Risk Score’
Review new PMP functionalities

pmpwebinar
Delivering XR Buprenorphine in a Maine Practice

September 27, 2022 | Eva Quirion, NP, PhD

Explore the delivery of XR buprenorphine with a focus on practical issues. Challenges and successes of the use of the XR buprenorphine will be highlighted.

Learning objectives:

Assess patients for XR buprenorphine
Describe induction and delivery (practice tips on injection)
Name challenges and success with the use of XR buprenorphine

MaineCare Services: Opioid Health Home (OHH) New Adopted Rule

September 14, 2022 | Kaley Boucher

The program will review the recent changes to the Opioid Health Home (OHH) model and regulation. The new updates provide increased flexibility and care coordination across programs. The changes will be highlighted and there will be opportunities for questions and answers.

Objectives:

Describe the various tiers of the Opioid Health Home model
Highlight changes from the previous MaineCare OHH regulations
Identify the advantages of value-based payment models

Promising Practices: Groups Recover Together: How they deliver (and measure) outcomes for Mainers with OUD

Comorbidities in Psychiatry: Prescribing Pearls

August 24, 2022 | Dr. Laurie Deerfield

This presentation will assist prescribers in their conceptualization and understanding of different diagnostic categories and ways psychiatric presentations may overlap to guide their choice of agents to treat complex medical psychiatric and substance issues appropriately without exacerbating other comorbid issues. Topics will include the how fentanyl influences those decisions, tips on reading confirmation substance testing, and ways to avoid precipitated withdrawal and the phenomenon known collectively as “restless leg syndrome.” Topics will include treating substance use disorders and anxiety, depression, and bipolar spectrums as well as depressive disorder sub types among others as time allows.

Buprenorphine and Pain

August 9, 2022 | Stephanie Nichols, PharmD, BCPS, BCPP, FCCP

This session will review the interface and nuances of the use of buprenorphine in a person with pain. We will review multiple angles, including both the treatment of acute and chronic pain in a person receiving buprenorphine for OUD and the use of buprenorphine to treat pain (with or without OUD).

Learning objectives:

Compare and contrast the various formulations of buprenorphine including consideration of FDA indication, route of administration, and dose
Identify the clinical result of using buprenorphine in a person who is opioid naive and in a person who is currently using other medical or nonmedical opioids
Describe the efficacy and clinical pearls associated with the use of buprenorphine patch and transmucosal forms for analgesia in a person with and without OUD
Identify emerging and best practices regarding treatment of acute and chronic pain in a person receiving buprenorphine for OUD

Early Recovery: Shifts in Focus

July 27, 2022 | Todd Mandell, MD

The early recovery period is critical to supporting ongoing recovery efforts. There are many pitfalls, with continued disruption of sleep, mood fluctuations and changing ways to care for yourself. Dr. Mandell will explore these areas providing tips about when and what might be helpful for pharmacological and treatment considerations.

Learning objectives:

Participants will be able to assist patients with the identification of post-withdrawal symptoms and refer for management.
Participants will be able to provide patients with education and skills regarding affect management as it pertains to recovery.
Participants will be able to address within their scope of practice issues such as overall well-being and self-care including healthy nutrition and sleep hygiene.

Promising Practice: St Joseph’s Healthcare XR Buprenorphine Practice: Successes and Challenges

New Strategies to Initiate Burprenorphine

June 14, 2022 | Stephanie Nichols, PharmD, BCPS, BCPP

This session will review the initiation of buprenorphine for OUD using the microdosing and macrodosing approaches. We will review why these emerging approaches are preferable to traditional approaches, the supporting evidence, and the practical pearls for implementation.

Learning Objectives:

Describe microdosing and macrodosing approaches to buprenorphine initiation
Recall the evidence supporting each of these approaches
Discuss practical pearls regarding these approaches when applied to patient care

Principles in Pain Care

June 29, 2022 | Eva Quirion, NP, PhD

How best to assess pain to offer non-opioid medication and non-medication treatments based upon the patient needs will be explored. Pertinent to this assessment is learning how to distinguish between peripheral pain and centralized pain.

Learning objectives:

Assess patients with chronic pain to offer non-opioid medications and non-medication treatments based on patient needs.
Distinguish between peripheral pain and centralized pain in order to identify treatments most likely to be helpful.

Peer Support Roles in Primary Care: How does it work?

July 12, 2022 | Carol Squires, Dr. Kristine Silvia, Michael Niles, and Randy Morrison

Peer recovery partners in primary care foster connection, engagement, and support with self-directed recovery pathways. The panel will discuss their journey working together in primary care settings – what’s worked, lessons learned, how they collaborate as a team to support patients. The panel will consist of a physician, clinician, and peer support staff who have created this type of partnership.

Learning objectives:

Discuss peer support roles in primary care settings.

Promising Practice: PenBay Family Medicine Rockport: Making Effective Workflows in Primary Care

Promising Practice: Gilman Clinic: Tips on Treating Hepatitis C in Individuals with SUD/OUD

Promising Practice: Integration of Peers into Medical Practices Treating SUD

Promising Practice: Expanding treatment programs to higher acuity patients

Best Practice of the Use of Extended Release Buprenorphine and Naltrexone

May 4, 2022 | John Mariani, MD

The presenter will explore the promising and best practices on the use of XR Buprenorphine and naltrexone. The ways the medications can be delivered and practical issues of certification in the SUBLOCADE REMS program, storage, and administration will be discussed.

Learning objectives:

Assess which patients are appropriate for treatment with the extended release (XR) formulation of Buprenorphine and Naltrexone.
Familiarize with the induction and monitoring processes for XR Buprenorphine and XR Naltrexone. Familiarize with delivery, storage, and administration (including certification in the Sublocade REMS Program).

Promising Practice: York Recovery Center

Data Collection: Assessing the Complex Patient

April 5, 2022 | Todd Mandell, MD, FASAP

The presenter will explore how to assess and use evidence based resources and tools to begin to identify the interrelations between SUD and psychiatric conditions to direct treatment approaches. Interactive case studies will be used for discussion.

Learning objectives:

Identify ways that SUD can mimic functional psychiatric conditions.
Complete an HPI with a focus on the reasons that brought the patient to seek treatment.
Identify a plan to utilize evidence based resources/tools as part of their assessment process.

data-analytics
Maine Penobscot Community Health Center Bridge policies – Bridge Clinic Residential Treatment Policy

Purpose:
To describe best practice for navigating prescriptions when patients are unable to present to the
office for prescription refills due to residential treatment.

Maine Penobscot Community Health Center Bridge policies – Bridge Clinic Witnessed Daily Dosing

Purpose:
To describe the purpose of the Witnessed Daily Dosing within the Bridge Clinic and related
protocols for treating patients.

Maine Penobscot Community Health Center Bridge policies – Bridge Clinic Telehealth Witnessed Daily Dosing

Purpose:
To describe the purpose of the Telehealth Witnessed Daily Dosing within the Bridge Clinic and
related protocols for treating patients.

Maine Penobscot Community Health Center Bridge policies- Bridge Clinic Policy & Procedure

Purpose:
To describe the purpose of the Bridge Clinic Program and related protocols for treating patients.

Maine Penobscot Community Health Center Bridge policies- Bridge Clinic Sedation Policy

Purpose:
To manage a patient who has overdosed or is near overdose safely, while minimizing PCHC and staff
liability. We want to ensure that all patients are treated as they wish, while also maintaining their
safety and the safety of the clinic

NIDA Clinical Trials Network Dissemination

About the CTN DI Initiative
The CTN Dissemination Initiative aims to reduce the gap that exists between the publication of research on treatment of substance use disorders and implementation in clinical practice. It incorporates collaboration among clinicians, researchers, and experienced trainers to develop user-friendly tools and products to facilitate the adoption of research-based interventions into clinical settings. Explore this page for more information about the different components of the CTN Dissemination Initiative.

Opioid Use Among Adolescents & Young Adults: Toolkit for Pediatric & Primary Care Providers

DESCRIPTION
Item Number: SA5829

This toolkit has been developed specifically for pediatric, primary care, and other health professionals treating adolescents and young adults within their medical practice. It provides guidance in regard to the medical, psychological, and social needs of adolescents and young adults with opioid use disorders, thereby improving physical and mental health outcomes. It has been developed to help primary care and pediatric health providers advance the clinical interventions by offering developmentally appropriate screening, treatment engagement, and coordinated care. A specific focus on evidence-based practices includes Medication for Opioid Use Disorder (MOUD) guidance and resources to support these clinical interventions.

American Association for the Study of Liver Disease, HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Welcome to HCVGuidelines.org
The AASLD and IDSA in partnership with the panel have created an updated web experience to facilitate easier and faster access to this important resource. Please select a patient profile from the menu above, click on a guidance section below, or use the search box to begin.

American Association for the Study of Liver Disease, Simplified HCV Treatment, without and with Compensated Cirrhosis

Simplified HCV Treatment Algorithm for Treatment-Naive Adults With Compensated Cirrhosis
Who Is NOT Eligible for Simplified Treatment
Patients who have any of the following characteristics:

Current or prior episode of decompensated cirrhosis, defined as Child-Turcotte-Pugh (CTP) score ≥7 (ascites, hepatic encephalopathy, total bilirubin >2.0 mg/dL, albumin ≤3.5 g/dL, or INR ≥1.7)
Prior hepatitis C treatment
End-stage renal disease (ie, eGFR <30 mL/min/m2) (see Patients with Renal Impairment section) HIV and/or HBsAg positive Current pregnancy Known or suspected hepatocellular carcinoma Prior liver transplantation (see HCV guidance for treatment recommendations for these patients)

National Institute on Drug Abuse: Matrix Model

The Matrix Model provides a framework for engaging stimulant (e.g., methamphetamine and cocaine) abusers in treatment and helping them achieve abstinence. Patients learn about issues critical to addiction and relapse, receive direction and support from a trained therapist, and become familiar with self-help programs. Patients are monitored for drug use through urine testing.

U.S. Department of Agriculture

Resources for Substance Use Disorder and Opioid Misuse Prevention, Treatment, and …

AdCare Educational Institute of Maine

TRAININGS & EVENTS We bring audiences quality continuing education with expert, nationally recognized trainers. Our …

Co-Occurring Collaborative Serving Maine

Who We Are The Co-Occurring Collaborative Serving Maine advocates for best practices, encourages professional development, …

Health and Human Services, Adolescent Health

Alcohol Use in Adolescence Adolescents use alcohol more than any other drug, including tobacco and …

patient-provider-information
Maine Chapter, American Academy of Pediatrics, Substance Use/Opioid Treatment Resources

Youth Peer Support Statewide Network now accepting referrals for youth peer support! Maine Behavioral Healthcare …

HRSA Regional rural Communities Opioid Response Program (RCORP) Grantees

Implementation RCORP-Implementation will advance RCORP’s overall goal by strengthening and expanding SUD/OUD prevention, treatment, and …

Maine Maternal Opioid Misuse (MOM) Initiative

MaineMOM aims to improve care for pregnant and postpartum people with opioid use disorder and their infants by integrating …

, echo ta
Northeast Telehealth Resource Center (NETRC), SUPPORT for ME Telehealth and Substance Use Disorder Training and Toolkit

You are invited to take a complimentary self-paced course in Telehealth and Substance Use Disorder (SUD) Treatment and …

ta
JSI Treating Addiction in Rural Areas (TARA)

We will develop the Treating Addiction in Rural Areas ECHO as part of HRSA’s Telehealth Technology-Enabled Learning …

echo
University of New Hampshire Project ECHO

UNH is a Project ECHO® Hub led by the NH Citizens Health Initiative, a program …

echo
Maine Health Access Foundation

The Systems Improvement and Innovation Responsive Grants (SIIRG) program provides funding for organizations working to …

Maine Primary Care Association and Penobscot Community Health Center, Low Barrier Treatment for Opioid Use Disorder Initiative

BANGOR, Maine, Nov. 10—An innovative program expanding low-barrier treatment for opiate use disorder—potentially serving thousands …

, echo ta
Maine Association of Psychiatric Physicians Listserv, Consultation & Conference

The Maine Association of Psychiatric Physicians (MAPP) is the Maine District Branch of the American …

ta
Boston Children’s Hospital Adolescent Substance Use & Addiction Program TIP Sheets

Sample Tip Sheet content: Choose one or a small number (< 5) of behaviors to …

, patient-provider-information tips
SAMHSA Publications and Digital Products

An up to date list of Publications and Digital Products from …

SAMHSA TIP 63: Medications for Opioid Use Disorder

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration …

Health and Human Services Department, Federal Register, Practical Guidelines for Administration of Buprenorphine for Treating Opioid Use Disorder (4/28/21)

AGENCY: Office of the Secretary, Department of Health and Human Services. ACTION: Notice. SUMMARY: The …

SAMHSA Buprenorphine Quick Start Guide

Facts About Buprenorphine   FDA approved for Opioid Use Disorder treatment in an officebased setting. …

, provider-information tips
SAMHSA Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings

Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings This resource provides information …

MaineCare Opioid Health Home, sample attestation language

Sample spread sheet : OHH Attestation for Service/Billing Month of 6/21/19-7/20/19 Organization Name Enter attestation …

MaineCare Opioid Health Home, OHH billing sheet 6.10.22

Sample spreadsheet: NOTES: ** These services may be delivered face-to-face, via phone or other media, …

MaineCare Opioid Health Home

Health Homes Health Homes, Behavioral Health Homes, and Opioid Health Homes The three health home …

Alosa Health, Clinical Modules, Opioids in Acute Pain and Chronic Pain, OUD

EVIDENCE BASED CLINICAL MODULES Alosa Health produces educational materials on common primary care topics that …

U.S. Department of Veterans Affairs, National Center for PTSD

We are the world’s leading research and educational center of excellence on PTSD and traumatic stress. …

psychotherapy
U.S. Department of Veterans Affairs, Helping Patients Taper from Benzodiazepine

Benzodiazepines Overview Continuing to renew benzodiazepine (BZ) prescriptions to certain subgroups of your patients with …

U.S. Department of Veterans Affairs, Opioid Safety

VHA Pain Management Opioid Safety – Clinical Tools his section provides links to a variety …

educational-resources
U.S. Department of Veterans Affairs, Pain Management

VHA Pain Management For Providers Chronic pain is among the most common, disabling, and costly …

Washington State Agency Medical Directors’ Group – MME calculator

Instructions: Fill in the mg per day* for whichever opioids your patient is taking. The web page …

Washington State Agency Medical Directors’ Group Opioid Dosing

AMDG agency medical directors’ group “A collaboration of state agencies, working together to improve health …

University of Vermont Center on Rural Addiction

Helping patients by helping providers. UVM CORA’s mission is to expand addiction-treatment capacity in HRSA-designated …

ta
University of Vermont Center on Rural Addiction Resource page: Provide E-learning and Webinars and other Resources related SUD/OUD

Reports, recorded webinars and events for rural providers and health, behavioral health and substance use …

The ATTCS Self paced web based Contingency Management Course

New Online Course: Contingency Management for Healthcare Settings Publication Date: Apr 30, 2020 Share This! …

The Addiction Files with Darlene Petersen, MD and Paula Cook, MD

The Addiction Files Darlene Petersen, MD and Paula Cook, MD 37 episodes Darlene Petersen MD …

Shatter Proof

The Shatterproof Addiction Stigma Index Shatterproof and The Hartford co-developed the Shatterproof Addiction Stigma Index …

SAMHSA Peer Recovery Center of Excellence

Peer Recovery Center of Excellence The Peer Recovery Center of Excellence is a peer-led national …

SAMHSA Mental Health Technology Transfer Center Network

About the MHTTC Network   Years of research and knowledge of evidence-based practices show that …

ta
SAMHSA LGBTQ+ Behavioral Health Equity Center of Excellence

LGBTQ+ Behavioral Health Equity Center of Excellence The Center of Excellence on LGBTQ+ Behavioral Health …

ta
National, Opioids, Chronic Pain, MAT/MOUD, Prescribing

At the Recovery Research Institute (RRI), we present the evidence about addiction treatment and recovery. …

Providers Clinical Support System

PCSS is a program funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) …

Oregon Pain Guidance

Pain Treatment Guidelines Introduction For the past few decades, a conceptual shift has taken place …

educational-resources
Opioid Response Network

Opioid Response Network The Substance Abuse and Mental Health Services Administration (SAMHSA) funded the State …

ta
New England PTTC

New England PTTC   The New England Prevention Technology Transfer Center, administered by AdCare Educational Institute of …

ta
New England MHTTC

New England MHTTC   The core mission of the New England MHTTC is to use …

ta
New England Addiction Technology Transfer Center

About the ATTC Network Who We Are The ATTC Network is an international, multidisciplinary resource …

ta
National Network to Eliminate Disparities in Behavioral Health

The National Network to Eliminate Disparities in Behavioral Health (NNED) is a network of community-based organizations focused …

ta
National Institute on Drug Abuse: NIDAMED: Clinical Resources: Opioid Crisis and Pain Management

National Institute on Drug Abuse NIDA is the lead federal agency supporting scientific research on …

practices
National Hispanic and Latino MHTTC

National Hispanic and Latino MHTTC   Our mission is to provide high-quality training and technical …

ta
National Harm Reduction Coalition: Training Guide: Getting Off Right: A safety Manual for Injection Drug Users

Training Guide GETTING OFF RIGHT: A SAFETY MANUAL FOR INJECTION DRUG USERS Introduction Disclaimer: This …

ME Governor’s Office of Policy Innovation and the Future Opioid Response

Opioid Response Governor Mills is committed to combatting the opioid crisis and protecting Maine families. …

Maine Health Substance Use Disorder Treatment Resources and Training

Substance Use Disorder Treatment Resources and Training With the understanding that substance use disorder (SUD) …

educational-resources
Maine Overdose Prevention Through Intensive Outreach Naloxone and Safety (OPTIONS) Initiative

About OPTIONS The Overdose Prevention Through Intensive Outreach Naloxone and Safety (OPTIONS) initiative is a …

Maine Independent Clinical Information Service (MICIS)

MICIS   MICIS, the Maine Independent Clinical Information Service, is an innovative educational outreach program …

Maine Drug Data Hub

Maine Drug Data Hub The Maine Drug Data Hub is a collaboration between several state …

Maine Department of Health and Human Services Prescription Monitoring Program

Prescription Monitoring Program The Prescription Monitoring Program (PMP) is a secure database that is used …

pmplink
Governor’s Opioid Response Summit Webinars

Governor Mills Opioid Response Summit & Seminars are part of the state’s strong commitment to …

U.S. Centers for Disease Control and Prevention Opioids Updating of CDC Opioid Prescribing Guideline

Process for Updating the Opioid Prescribing Guideline The draft 2022 CDC Clinical Practice Guideline for …

U.S. Centers for Disease Control and Prevention Opioids

Safer Prescribing Saves Lives: Opioid Prescribing Guideline Chronic pain is common, multidimensional, and individualized. Treatment …

, practices tips
Maine Medical Association, Center for Quality Improvement

The MMA-CQI Learning Lab has been designed to support health care practitioners and professionals, and …

CA Bridge

Our vision is that all people who use drugs will have access to evidence-based treatment …

Boston Medical Center Office Based Addiction Treatment Training and Technical Assistance

Boston Medical Center (BMC) Office Based Addiction Treatment (OBAT) Training and Technical Assistance (TTA) Expanding …

American Society of Addiction Medicine 

Who is AAFP? Our mission is simple: Strengthen family physicians and the communities they care …

American Academy of Family Physicians: Chronic Pain Management Toolkit

INTRODUCTION Chronic pain is common in the U.S., with anywhere from 11% to 40% of …

Agency for Healthcare Research and Quality Opioids and Substance Use Disorder

Agency for Healthcare Research and Quality: A Profile The Agency for Healthcare Research and Quality …

data-analytics
Addiction Technology Transfer Center Network

The ATTC Network is an international, multidisciplinary resource for professionals in the addictions treatment and …

ta